David Grimwade
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 119
- Acute Myeloid Leukemia Research 114
- Chronic Myeloid Leukemia Treatments 19
-
- Retinoids in leukemia and cellular processes 85
- Protein Degradation and Inhibitors 16
- Advanced biosensing and bioanalysis techniques 15
- Co-authors
- Alan K. Burnett (37 shared papers)Keith Wheatley (24 shared papers)Robert K. Hills (36 shared papers)Christine J. Harrison (10 shared papers)Helen M. Walker (9 shared papers)Anthony P. Goldstone (12 shared papers)Anthony H. Goldstone (6 shared papers)Sylvie Freeman (16 shared papers)
- Journals
- Blood (49 papers)British Journal of Haematology (23 papers)Leukemia (13 papers)Genes Chromosomes and Cancer (5 papers)Journal of Clinical Oncology (5 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
David Grimwade
149 papers receiving 15.4k citations
David Grimwade's Hit Papers
Peers
Comparison fields: 5 of 120
- Hematology 11.8k
- Genetics 2.4k
- Public Health, Environmental and Occupational Health 3.7k
- Molecular Biology 7.7k
- Biochemistry 528
Countries citing papers authored by David Grimwade
This map shows the geographic impact of David Grimwade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Grimwade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Grimwade more than expected).
Fields of papers citing papers by David Grimwade
This network shows the impact of papers produced by David Grimwade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Grimwade. The network helps show where David Grimwade may publish in the future.
Co-authors
The 25 scholars most cited alongside David Grimwade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet Hit paper breakdown → | 2009 | 2370 |
| 2 | The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial Hit paper breakdown → | 1998 | 2096 |
| 3 | Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials Hit paper breakdown → | 2010 | 1298 |
| 4 | Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program Hit paper breakdown → | 2003 | 1101 |
| 5 | The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial Hit paper breakdown → | 2001 | 711 |
| 6 | Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet Hit paper breakdown → | 2008 | 610 |
| 7 | 2015 | 350 | |
| 8 | 2009 | 333 | |
| 9 | 1999 | 311 | |
| 10 | 2010 | 311 | |
| 11 | 2015 | 293 | |
| 12 | 2009 | 241 | |
| 13 | 2013 | 230 | |
| 14 | 2000 | 224 | |
| 15 | 2005 | 199 | |
| 16 | 2010 | 196 | |
| 17 | 2014 | 189 | |
| 18 | 2014 | 160 | |
| 19 | 1998 | 147 | |
| 20 | 2018 | 141 |
About David Grimwade
David Grimwade is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Genetics and Immunology, having authored 151 papers that have together received 15.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (114 papers), Retinoids in leukemia and cellular processes (85 papers), Acute Lymphoblastic Leukemia research (41 papers), Chronic Myeloid Leukemia Treatments (19 papers), Protein Degradation and Inhibitors (16 papers), Advanced biosensing and bioanalysis techniques (15 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Drug-Induced Ocular Toxicity (8 papers). The work is most often cited by research in Hematology (11.8k citations), Genetics (2.4k citations), Public Health, Environmental and Occupational Health (3.7k citations), Molecular Biology (7.7k citations) and Biochemistry (528 citations). David Grimwade has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Alan K. Burnett, Keith Wheatley, Robert K. Hills, Christine J. Harrison, Helen M. Walker, Anthony P. Goldstone, Anthony H. Goldstone, Sylvie Freeman, Ian Hann and Fiona Oliver. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Genes Chromosomes and Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.